You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Soft Tissue Sarcoma, Advanced Epithelioid Sarcoma Trial in Worldwide (Tazemetostat, Placebo, Doxorubicin HCl)

Recruiting
  • Advanced Soft Tissue Sarcoma
  • Advanced Epithelioid Sarcoma
  • Duarte, California
  • +20 more
Jan 31, 2022

Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Costa Mesa, California
  • +49 more
Aug 24, 2022

Sarcoma,Soft Tissue, Sarcoma Uterus Trial in United States (Niraparib)

Recruiting
  • Sarcoma,Soft Tissue
  • Sarcoma Uterus
  • Basking Ridge, New Jersey
  • +6 more
Aug 23, 2022

Breast Tumors, Radiotherapy, Lymphedema Trial in Canada (Locoregional radiation treatment - Conventional fractionation,

Recruiting
  • Breast Neoplasms
  • +2 more
  • Locoregional radiation treatment - Conventional fractionation
  • Locoregional radiation treatment - Hypofractionation
  • Calgary, Alberta, Canada
  • +12 more
May 26, 2022

Breast Tumor, Brain Metastases, Triple Negative Breast Cancer Trial in Toronto (MRI screening)

Unknown status
  • Breast Neoplasm
  • +3 more
  • MRI screening
  • Toronto, Ontario, Canada
    Sunnybrook Odette Cancer Centre
Mar 16, 2019

Squamous NSCLC Trial in Worldwide (Carboplatin, Veliparib, Paclitaxel)

Completed
  • Squamous Non-Small Cell Lung Cancer
  • Jonesboro, Arkansas
  • +224 more
Nov 13, 2020

Circulating Tumor Cells in mCRC for Liver Resection

Unknown status
  • Metastatic Colorectal Cancer
  • Circulating Tumor Cell
  • Circulating tumor cell
  • Hong Kong, Hong Kong
    The University of Hong Kong
Nov 17, 2018

Prostate Cancer Trial in Hamilton, London, Toronto (18F-DCFPyL PET/CT scan)

Completed
  • Prostate Cancer
  • 18F-DCFPyL PET/CT scan
  • Hamilton, Ontario, Canada
  • +3 more
Mar 24, 2022

HER2-expressing Cancers Trial in United States (Zanidatamab, Evorpacept)

Recruiting
  • HER2-expressing Cancers
  • Birmingham, Alabama
  • +11 more
Apr 8, 2022

Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer Trial in Shenyang (irinotecan)

Unknown status
  • Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer
  • Shenyang, Liaoning, China
    SunTao
Sep 1, 2018

Healthcare Resource Utilization and Costs of Immune Checkpoint

Completed
  • Melanoma
    • East Hanover, New Jersey
      Novartis
    May 12, 2023

    Biliary Tract Cancer Trial in Worldwide (NUC-1031, Gemcitabine, Cisplatin)

    Terminated
    • Biliary Tract Cancer
    • Tucson, Arizona
    • +124 more
    Mar 16, 2022

    Pancreatic Cancer, Advanced Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in New York, Charlottesville

    Active, not recruiting
    • Pancreatic Cancer
    • +3 more
    • anti-EGFR-bispecific antibody armed activated T-cells
    • New York, New York
    • +1 more
    Oct 7, 2021

    Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Beverly Hills, Los Angeles

    Recruiting
    • Advanced Pancreatic Adenocarcinoma
    • +2 more
    • Beverly Hills, California
    • +1 more
    Jun 16, 2022

    Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue

    Recruiting
    • Castration Levels of Testosterone
    • +4 more
    • Abiraterone Acetate
    • +6 more
    • Fairbanks, Alaska
    • +671 more
    Dec 29, 2021

    Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone 5 mg twice daily, Prednisone 5 mg once daily)

    Completed
    Has Results
    • Prostate Cancer
    • Abiraterone Acetate
    • +4 more
    • Aalst, Belgium
    • +16 more
    Jul 2, 2019

    Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old

    Active, not recruiting
    • Rhabdomyosarcoma
      • Bordeaux, France
      • +19 more
      Jul 19, 2022

      Nasopharyngeal Carcinoma Trial (Envafolimab and recombinant human endostatin combined with chemoradiotherapy)

      Not yet recruiting
      • Nasopharyngeal Carcinoma
      • Envafolimab and recombinant human endostatin combined with chemoradiotherapy
      • (no location specified)
      Sep 23, 2023

      Solid Tumor, Soft Tissue Sarcoma, Gastric Cancer Trial in Shanghai (CCT301-59)

      Active, not recruiting
      • Solid Tumor
      • +4 more
      • CCT301-59
      • Shanghai, Shanghai, China
        Shanghai Zhongshan Hospital
      Oct 19, 2021

      Breast Cancer Female Trial in Shanghai (sentinel lymph node biopsy or targeted axillary dissection alone)

      Recruiting
      • Breast Cancer Female
      • sentinel lymph node biopsy or targeted axillary dissection alone
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Nov 20, 2021

      Overall Survival in Patients Receiving Best Supportive Care for

      Withdrawn
      • Metastatic Colorectal Carcinoma
      • Observational
      • Bronx, New York
        Calvary Hospital
      Aug 28, 2018

      Metastatic Breast Cancer Trial in Baltimore (Treatment suggestion)

      Completed
      • Metastatic Breast Cancer
      • Treatment suggestion
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Feb 27, 2019

      MEtatastic Renal Carcinoma LINes

      Unknown status
      • Renal Cell Carcinoma
        • Besançon, France
        • +7 more
        Apr 26, 2019

        Needs and Preferences of Patients With Head-neck Cutaneous SCC

        Active, not recruiting
        • Cutaneous Squamous Cell Carcinoma
        • +10 more
        • Regular care with additional administration of a semi-structured interview
        • Maastricht, Netherlands
          Maastricht University Medical Center+
        Sep 13, 2023

        Solid Tumors Trial in Ryazan' (TAB08)

        Completed
        • Solid Tumors
        • Ryazan', Russian Federation
          GBU Ryazanskoy Oblasti "Oblastnoy klinicheckiy oncologicheskiy d
        Oct 5, 2021